managementranepaУправленческое консультированиеAdministrative Consulting1726-11391816-8590Russian Presidential Academy of National Economy and Public Administration. North-West Institute of Management.10.22394/1726-1139-2022-7-163-184managementranepa-2046Research ArticleОБЩЕСТВО И РЕФОРМЫSOCIETY AND REFORMSВлияние расходов на здравоохранение на смертность от COVID-19The Impact of Health Expenditure on COVID-19 mortalityОвсянниковаМ. А.OvsiannikovaM. A.

Овсянникова Мария Алексеевна, студент департамента экономики

Санкт-Петербург

Mariia A. Ovsiannikova, student of Department of Economics

Saint Petersburg

maovsyannikova_1@edu.hse.ruНациональный исследовательский университет «Высшая школа экономики»HSE Campus in St. Petersburg20221210202207163184Copyright © Овсянникова М.А., 20222022Овсянникова М.А.Ovsiannikova M.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.acjournal.ru/jour/article/view/2046

В данной статье исследуется степень, в которой общенациональные расходы на здравоохранение (в качестве меры готовности к пандемии) снижают смертность от COVID-19. Для проверки гипотез используются данные по 96 странам мира. В странах с низким уровнем дохода обнаружено статистически значимое негативное влияние увеличения расходов на здравоохранение на ожидаемую смертность. Этот эффект для стран со средним и высоким уровнем дохода незначителен. Основными угрозами внутренней валидности этого исследования являются пропущенная переменная и смещение выборки. Предлагаются некоторые способы, на которых можно построить дальнейшее исследование.

The present study investigates the degree to which countrywide health expenditures as a measure of pandemic preparedness reduce mortality from COVID-19, using data on 96 countries of the world. A statistically significant negative effect of higher health expenditure on expected mortality is found for low-income countries. This effect for middle- and high-income countries is insignificant. Leading threats to the internal validity of this study are omitted variable bias and sample selection bias. Some ways in which this study can be built upon are suggested.

пандемиярасходы на здравоохранениеповедениесмертностьстраныуровень доходаpandemichealth expenditurebehaviormortalitycountriesincome levelReferencesElola-Somoza F. J., Bas-Villalobos M. C., P´erez-Villacast´ın J., MacayaMiguel C. Public healthcare expenditure and COVID-19 mortality in Spain and in Europe. Revista Cl´ınica Espanola (English Edition). 2021. Vol. 221. N 7. P. 400–403.Elola-Somoza F. J., Bas-Villalobos M. C., P´erez-Villacast´ın J., MacayaMiguel C. Public healthcare expenditure and COVID-19 mortality in Spain and in Europe. Revista Cl´ınica Espanola (English Edition). 2021. Vol. 221. N 7. P. 400–403.Fetzer T., Witte M., Hensel L., Jachimowicz J. M. et. al. Global Behaviors and Perceptions in the COVID-19 Pandemic. PsyArXiv Preprints. 2021. P. 77.Fetzer T., Witte M., Hensel L., Jachimowicz J. M. et. al. Global Behaviors and Perceptions in the COVID-19 Pandemic. PsyArXiv Preprints. 2021. P. 77.Gupta A. K., Nethan S. T., Mehrotra R. Tobacco use as a well-recognized cause of severe COVID-19 manifestations. Respiratory Medicine. 2020. N 176. P. 106233.Gupta A. K., Nethan S. T., Mehrotra R. Tobacco use as a well-recognized cause of severe COVID-19 manifestations. Respiratory Medicine. 2020. N 176. P. 106233.Kapitsinis N. The underlying factors of the COVID-19 spatially uneven spread. Initial evidence from regions in nine EU countries. Regional Science Policy Practice. 2020. Vol. 12. N 6. P. 1027–1045.Kapitsinis N. The underlying factors of the COVID-19 spatially uneven spread. Initial evidence from regions in nine EU countries. Regional Science Policy Practice. 2020. Vol. 12. N 6. P. 1027–1045.Khan J. R., Awan N., Islam M., Muurlink O. Healthcare capacity, health expenditure, and civil society as predictors of COVID-19 case fatalities: a global analysis. Frontiers in public health. 2020. N 8. P. 347.Khan J. R., Awan N., Islam M., Muurlink O. Healthcare capacity, health expenditure, and civil society as predictors of COVID-19 case fatalities: a global analysis. Frontiers in public health. 2020. N 8. P. 347.Oshinubi K., Rachdi M., Demongeot J. Analysis of Reproduction Number R0 of COVID-19 Using Current Health Expenditure as Gross Domestic Product Percentage (CHE/GDP) across Countries. Multidisciplinary Digital Publishing Institute. 2021. Vol. 9. N 10. P. 1247.Oshinubi K., Rachdi M., Demongeot J. Analysis of Reproduction Number R0 of COVID-19 Using Current Health Expenditure as Gross Domestic Product Percentage (CHE/GDP) across Countries. Multidisciplinary Digital Publishing Institute. 2021. Vol. 9. N 10. P. 1247.Zheng Z., Peng F., Xu B., Zhao J. et al. Risk factors of critical mortal COVID-19 cases: A systematic literature review and meta-analysis // Journal of infection. 2020. Vol. 81. N 2. P. 16–25.Zheng Z., Peng F., Xu B., Zhao J. et al. Risk factors of critical mortal COVID-19 cases: A systematic literature review and meta-analysis // Journal of infection. 2020. Vol. 81. N 2. P. 16–25.

The authors declare that there are no conflicts of interest present.